Back to company

Novo Nordisk North America Operations A/S: Financial statements 2013

CVR: 33761201

Novo Nordisk North America Operations A/S (CVR 33761201) has filed annual accounts for 2013. In 2013, the company reported a net result of DKK -27,000 compared with DKK -17,000 the year before. Equity amounted to DKK 445,000. The solvency ratio was 85.4%.

Profit/Loss
-27,000 kr.
Equity
445,000 kr.
Total Assets
521,000 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2013---27 t.445 t.-
2012---17 t.472 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Novo Nordisk North America Operations A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2013

Novo Nordisk North America Operations A/S: The 2012 annual report is outMay 9, 2013

Novo Nordisk North America Operations A/S has published its annual report for 2012. The net result was DKK -17,000.

About Novo Nordisk North America Operations A/S

Novo Nordisk North America Operations A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2011. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named Novo Nordisk Invest 3 A/S and NOVO NORDISK REGION NORTH AMERICA II A/S. The management consists of Anders Rytter Mikkelsen. The company is owned by NOVO NORDISK A/S. In 2025, the company reported a gross profit of DKK -59,000 and a net result of DKK -74,142,000 compared with DKK -89,167,000 the year before. Equity amounted to DKK 60,045,000.